Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Albuferon safe and active in phase II trial in hepatitis C patients

April 18, 2005

Idenix presents new data on drugs for chronic hepatitis

April 18, 2005

Remofovir reported to reduce viral load of patients with chronic hepatitis B

April 18, 2005

LB-80380 shows promise in the treatment of lamivudine-resistant hepatitis B

April 18, 2005

New sodium channel blockers emerge from Ionix R&D

April 14, 2005

New class of inhibitors of HBsAg secretion described

April 14, 2005

New data on the antiviral efficacy and the PK of celgosivir

April 13, 2005

Treatment begins in phase III study of tolevamer in CDAD

April 7, 2005

Not approvable letter for cilansetron for IBS-D

April 6, 2005

Biolipox claims novel antiinflammatory indole compounds

April 6, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...